
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10069544
[patent_doc_number] => 09107879
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-08-18
[patent_title] => 'Methods of increasing the cytotoxicity of chemotherapeutic agents with multisubstrate inhibitors of histone, protein-lys, polyamine acetylation, and polyamine metabolism'
[patent_app_type] => utility
[patent_app_number] => 13/078837
[patent_app_country] => US
[patent_app_date] => 2011-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 32
[patent_no_of_words] => 23916
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13078837
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/078837 | Methods of increasing the cytotoxicity of chemotherapeutic agents with multisubstrate inhibitors of histone, protein-lys, polyamine acetylation, and polyamine metabolism | Mar 31, 2011 | Issued |
Array
(
[id] => 6189929
[patent_doc_number] => 20110172213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'ENHANCEMENT OF EFFECTIVENESS OF 5-FLUOROURACIL IN TREATMENT OF TUMOR METASTASES AND CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/052532
[patent_app_country] => US
[patent_app_date] => 2011-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1367
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20110172213.pdf
[firstpage_image] =>[orig_patent_app_number] => 13052532
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/052532 | Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer | Mar 20, 2011 | Issued |
Array
(
[id] => 6160111
[patent_doc_number] => 20110159114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'COMBINATION COMPRISING AN IRON CHELATOR AND AN ANTI-NEOPLASTIC AGENT AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/044596
[patent_app_country] => US
[patent_app_date] => 2011-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17691
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20110159114.pdf
[firstpage_image] =>[orig_patent_app_number] => 13044596
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/044596 | COMBINATION COMPRISING AN IRON CHELATOR AND AN ANTI-NEOPLASTIC AGENT AND USE THEREOF | Mar 9, 2011 | Abandoned |
Array
(
[id] => 8995104
[patent_doc_number] => 08518989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Prodrugs of short-chain fatty acids and treatment methods'
[patent_app_type] => utility
[patent_app_number] => 13/039661
[patent_app_country] => US
[patent_app_date] => 2011-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 65
[patent_no_of_words] => 26883
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13039661
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/039661 | Prodrugs of short-chain fatty acids and treatment methods | Mar 2, 2011 | Issued |
Array
(
[id] => 5972754
[patent_doc_number] => 20110152269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'PROCESS FOR TREATING ANIMAL HABITATS'
[patent_app_type] => utility
[patent_app_number] => 13/037622
[patent_app_country] => US
[patent_app_date] => 2011-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3331
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20110152269.pdf
[firstpage_image] =>[orig_patent_app_number] => 13037622
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/037622 | PROCESS FOR TREATING ANIMAL HABITATS | Feb 28, 2011 | Abandoned |
Array
(
[id] => 8371531
[patent_doc_number] => 20120220921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'IMMUNOLOGICALLY MODIFIED CARBON NANOTUBES FOR CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/037171
[patent_app_country] => US
[patent_app_date] => 2011-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6120
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13037171
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/037171 | Immunologically modified carbon nanotubes for cancer treatment | Feb 27, 2011 | Issued |
Array
(
[id] => 9140396
[patent_doc_number] => 08580857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-12
[patent_title] => 'Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy'
[patent_app_type] => utility
[patent_app_number] => 13/031306
[patent_app_country] => US
[patent_app_date] => 2011-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12070
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13031306
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/031306 | Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy | Feb 20, 2011 | Issued |
Array
(
[id] => 6000955
[patent_doc_number] => 20110117211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to Disease of Mucosa'
[patent_app_type] => utility
[patent_app_number] => 13/013340
[patent_app_country] => US
[patent_app_date] => 2011-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25299
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117211.pdf
[firstpage_image] =>[orig_patent_app_number] => 13013340
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/013340 | Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to Disease of Mucosa | Jan 24, 2011 | Abandoned |
Array
(
[id] => 8671466
[patent_doc_number] => 20130046005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'TREATMENT OF IMMUNE DISORDERS USING KAINATE RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/574808
[patent_app_country] => US
[patent_app_date] => 2011-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12147
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574808
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/574808 | Treatment of immune disorders using kainate receptor antagonists | Jan 24, 2011 | Issued |
Array
(
[id] => 5943634
[patent_doc_number] => 20110104254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'Medicament for treatment of tumors wherein hedgehog/smoothened signaling is employed for inhibition of apoptosis of the tumor cells'
[patent_app_type] => utility
[patent_app_number] => 12/930677
[patent_app_country] => US
[patent_app_date] => 2011-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6729
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104254.pdf
[firstpage_image] =>[orig_patent_app_number] => 12930677
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/930677 | Medicament for treatment of tumors wherein hedgehog/smoothened signaling is employed for inhibition of apoptosis of the tumor cells | Jan 12, 2011 | Abandoned |
Array
(
[id] => 6016873
[patent_doc_number] => 20110224240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'METHODS OF TREATING CANCER AND RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/004656
[patent_app_country] => US
[patent_app_date] => 2011-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7929
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224240.pdf
[firstpage_image] =>[orig_patent_app_number] => 13004656
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/004656 | METHODS OF TREATING CANCER AND RELATED DISEASES | Jan 10, 2011 | Abandoned |
Array
(
[id] => 8708592
[patent_doc_number] => 20130065881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'Tricyclic Compounds for Use as Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/519872
[patent_app_country] => US
[patent_app_date] => 2010-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47234
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519872
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/519872 | Tricyclic compounds for use as kinase inhibitors | Dec 30, 2010 | Issued |
Array
(
[id] => 6039514
[patent_doc_number] => 20110092563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'STATIN AND OMEGA-3 FATTY ACIDS FOR LIPID THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/977109
[patent_app_country] => US
[patent_app_date] => 2010-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8050
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092563.pdf
[firstpage_image] =>[orig_patent_app_number] => 12977109
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/977109 | STATIN AND OMEGA-3 FATTY ACIDS FOR LIPID THERAPY | Dec 22, 2010 | Abandoned |
Array
(
[id] => 6048821
[patent_doc_number] => 20110207814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'Combination Therapy for Breast Cancer Treatment'
[patent_app_type] => utility
[patent_app_number] => 12/977036
[patent_app_country] => US
[patent_app_date] => 2010-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7211
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207814.pdf
[firstpage_image] =>[orig_patent_app_number] => 12977036
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/977036 | Combination Therapy for Breast Cancer Treatment | Dec 21, 2010 | Abandoned |
Array
(
[id] => 10000359
[patent_doc_number] => 09044432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-02
[patent_title] => 'Compositions and methods for cancer detection and treatment'
[patent_app_type] => utility
[patent_app_number] => 13/518828
[patent_app_country] => US
[patent_app_date] => 2010-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 9666
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518828
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/518828 | Compositions and methods for cancer detection and treatment | Dec 21, 2010 | Issued |
Array
(
[id] => 10505303
[patent_doc_number] => 09233162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-12
[patent_title] => 'High affinity VEGF-receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/950425
[patent_app_country] => US
[patent_app_date] => 2010-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 26
[patent_no_of_words] => 22823
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12950425
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/950425 | High affinity VEGF-receptor antagonists | Nov 18, 2010 | Issued |
Array
(
[id] => 6214221
[patent_doc_number] => 20110136826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/912098
[patent_app_country] => US
[patent_app_date] => 2010-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17848
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136826.pdf
[firstpage_image] =>[orig_patent_app_number] => 12912098
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/912098 | COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS | Nov 14, 2010 | Abandoned |
Array
(
[id] => 6187982
[patent_doc_number] => 20110171289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/912110
[patent_app_country] => US
[patent_app_date] => 2010-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17851
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171289.pdf
[firstpage_image] =>[orig_patent_app_number] => 12912110
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/912110 | COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS | Nov 8, 2010 | Abandoned |
Array
(
[id] => 6214545
[patent_doc_number] => 20110136906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'USE OF HYDROXYOLEIC ACID AND RELATED COMPOUNDS IN THE MANUFACTURE OF DRUGS'
[patent_app_type] => utility
[patent_app_number] => 12/939641
[patent_app_country] => US
[patent_app_date] => 2010-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5848
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136906.pdf
[firstpage_image] =>[orig_patent_app_number] => 12939641
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/939641 | Use of hydroxyoleic acid and related compounds in the manufacture of drugs | Nov 3, 2010 | Issued |
Array
(
[id] => 6071360
[patent_doc_number] => 20110046211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'COMBINATION THERAPY OF HEDGEHOG INHIBITORS, RADIATION AND CHEMOTHERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/913459
[patent_app_country] => US
[patent_app_date] => 2010-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11532
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046211.pdf
[firstpage_image] =>[orig_patent_app_number] => 12913459
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/913459 | COMBINATION THERAPY OF HEDGEHOG INHIBITORS, RADIATION AND CHEMOTHERAPEUTIC AGENTS | Oct 26, 2010 | Abandoned |